[Federal Register Volume 62, Number 147 (Thursday, July 31, 1997)]
[Notices]
[Pages 41051-41052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20136]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement Number 789]


Research and Demonstration Programs in Surveillance, Prevention, 
and Control of Healthcare-Associated Infections and Antimicrobial 
Resistant Infections

Amendment

    A notice announcing the availability of fiscal year (FY) 1997 funds 
for cooperative agreements for Research and Demonstration Programs in 
Surveillance, Prevention, and Control of Healthcare-Associated 
Infections and

[[Page 41052]]

Antimicrobial Resistant Infections was published in the Federal 
Register on July 8, 1997, (62 FR 36541). The notice is amended as 
follows:
    On page 36543, under the heading ``Specific Instructions,'' second 
column, 4. Objectives and Technical Approach, lines three and four have 
been changed and should read: ``Recipient Activities (A.1.a., A.1.b., 
A.2., A.3., and A.4.). . . .''
    On page 36544, second column, third paragraph, c., line six should 
read ``Activities A.4.). . . .''
    All other information and requirements of the July 8, 1997, Federal 
Register notice remain the same.

    Dated: July 25, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-20136 Filed 7-30-97; 8:45 am]
BILLING CODE 4163-18-P